Maria del Pilar Muñoz, vice-president in charge of M&A and Sustainability at Eurofarma, one of the largest and most innovative pharmaceutical companies in Brazil with operations in 20 countries across Latin Americ , provides insights into the key competitive advantages of Eurofarma, its unique internationalization strategy, and the company’s historical approach to following the highest governance standards.
Access to medication is at the company’s core; what we do is ensure scale gain so that we can have competitive costs and prices
